Biopharmaceutical company developing therapies for underserved patient populations
Vanda is a public biopharmaceutical company running clinical trials, licensing deals, and partnership financial modeling — a standard drug-development pipeline. The hiring mix reveals sales-heavy scaling (65 sales roles vs. 2 engineering): the company is executing a commercialization-focused growth strategy rather than building internal software capability. Pain points cluster around reimbursement access and sales-territory execution, not product development bottlenecks.
Vanda develops and commercializes therapies targeting high unmet medical needs. The company operates a full clinical pipeline (Phase I–IV studies), manages licensing and M&A transactions, and conducts stability and shelf-life studies to support regulatory submissions. Sales teams drive territory-level product adoption and manage reimbursement access. Operating out of Washington, DC, Vanda employs 201–500 staff and is publicly traded.
Vanda runs Salesforce for CRM, Python for data analysis, and Power BI for dashboards. Infrastructure spans Azure Entra ID, AWS, VMware vSphere, and Cisco networking. Frontend development uses React, Vue, and TypeScript.
Vanda is headquartered in Washington, DC and is a publicly traded company founded in 2003.
Vanda Pharmaceuticals's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.